Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status

被引:0
作者
Martinus A. Beek
Paul D. Gobardhan
Ernst J. P. Schoenmaeckers
Elisabeth G. Klompenhouwer
Harm J. T. Rutten
Adri C. Voogd
Ernest J. T. Luiten
机构
[1] Amphia Hospital,Department of Surgery
[2] The Netherlands Cancer Institute,Department of Radiology
[3] Catharina Hospital,Department of Surgery
[4] Maastricht University,GROW: School of Oncology and Developmental Biology
[5] Netherlands Comprehensive Cancer Organisation,Department of Research
来源
Breast Cancer Research and Treatment | 2016年 / 158卷
关键词
Axillary reverse mapping; Breast cancer; Lymphedema;
D O I
暂无
中图分类号
学科分类号
摘要
Axillary reverse mapping (ARM) is a technique by which the lymphatic drainage of the upper extremity that traverses the axillary region can be differentiated from the lymphatic drainage of the breast during axillary lymph node dissection (ALND). Adding this procedure to ALND may reduce upper extremity lymphedema by preserving upper extremity drainage. This review of the current literature on the ARM procedure discusses the feasibility, safety and relevance of this technique. A PubMed literature search was performed until 12 August 2015. A total of 31 studies were included in this review. The studies indicated that the ARM procedure adequately identifies the upper extremity lymph nodes and lymphatics in the axillary basin using blue dye or fluorescence. Preservation of ARM lymph nodes and corresponding lymphatics was proven to be oncologically safe in clinically node-negative breast cancer patients with metastatic lymph node involvement in the sentinel lymph node (SLN) who are advised to undergo a completion ALND. The ARM procedure is technically feasible with a high visualisation rate using blue dye or fluorescence. ALND combined with ARM can be regarded as a promising surgical refinement in order to reduce the incidence of upper extremity lymphedema in selected groups of patients.
引用
收藏
页码:421 / 432
页数:11
相关论文
共 327 条
[1]  
Tausch C(2013)Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Eur J Surg Oncol 39 880-886
[2]  
Baege A(2013)The changing role of axillary lymph node dissection for breast cancer Breast Cancer 20 41-46
[3]  
Dietrich D(2003)Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer Arch Surg 138 482-487
[4]  
Vergin I(2002)Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation Breast Cancer Res Treat 73 31-36
[5]  
Heuer H(2005)The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance J Surg Oncol 92 23-31
[6]  
Heusler RH(2006)Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 599-609
[7]  
Rageth C(2005)One-year morbidity after sentinel node biopsy and breast surgery Breast 14 28-36
[8]  
Noguchi M(2003)Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy Eur J Surg Oncol 29 341-350
[9]  
Morioka E(2000)Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma Cancer 88 608-614
[10]  
Ohno Y(2002)Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer Ann Surg Oncol 9 745-753